Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Am J Gastroenterol. 2012 Feb;107(2):276-85. doi: 10.1038/ajg.2011.340. Epub 2011 Oct 4.
Gut-directed hypnotherapy has been found to be effective in irritable bowel syndrome (IBS). However, randomized, controlled studies are rare and few have been performed outside highly specialized research centers. The objective of this study was to study the effect of gut-directed hypnotherapy in IBS in different clinical settings outside the traditional research units.
The study population included IBS patients refractory to standard management. In study 1, patients were randomized to receive gut-directed hypnotherapy (12 sessions, 1 h/week) in psychology private practices or supportive therapy, whereas patients were randomized to receive gut-directed hypnotherapy in a small county hospital or to serve as waiting list controls in study 2. Gastrointestinal symptom severity and quality of life were evaluated at baseline, at 3 months follow-up and after 1 year.
We randomized 138 IBS patients refractory to standard management, 90 in study 1 and 48 in study 2. In both the studies, IBS-related symptoms were improved at 3 months in the gut-directed hypnotherapy groups (P<0.05), but not in the control groups (ns). In study 1, a significantly greater improvement of IBS-related symptom severity could be detected in the gut-directed hypnotherapy group than in the control group (P<0.05), and a trend in the same direction was seen in study 2 (P=0.17). The results seen at 3 months were sustained up to 1 year.
Gut-directed hypnotherapy is an effective treatment alternative for patients with refractory IBS, but the effectiveness is lower when the therapy is given outside the highly specialized research centers.
肠导向催眠疗法已被证明对肠易激综合征(IBS)有效。然而,随机对照研究很少,且很少在高度专业化的研究中心之外进行。本研究的目的是研究肠导向催眠疗法在传统研究单位之外的不同临床环境中对 IBS 的疗效。
研究人群包括对标准治疗无反应的 IBS 患者。在研究 1 中,患者被随机分配接受肠导向催眠治疗(12 次,每周 1 小时),在心理学私人诊所或支持性治疗,而患者被随机分配在一个小县城医院接受肠导向催眠治疗或作为候补名单对照组在研究 2 中。在基线、3 个月随访和 1 年后评估胃肠道症状严重程度和生活质量。
我们随机分配了 138 名对标准治疗无反应的 IBS 患者,其中 90 名在研究 1 中,48 名在研究 2 中。在两项研究中,肠导向催眠治疗组在 3 个月时 IBS 相关症状均有改善(P<0.05),但对照组无改善(无统计学意义)。在研究 1 中,肠导向催眠治疗组的 IBS 相关症状严重程度改善明显大于对照组(P<0.05),研究 2 中也出现了同样的趋势(P=0.17)。3 个月时的结果持续到 1 年。
肠导向催眠疗法是治疗难治性 IBS 的有效替代方法,但在高度专业化的研究中心之外,其疗效较低。